Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients

J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1142-1145. doi: 10.1016/j.jaip.2016.12.033. Epub 2017 Mar 9.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Angioedemas, Hereditary / drug therapy*
  • Angioedemas, Hereditary / epidemiology
  • Child
  • Clinical Protocols
  • Complement C1 Inhibitor Protein / therapeutic use*
  • Drug-Related Side Effects and Adverse Reactions / epidemiology
  • Europe / epidemiology
  • Female
  • Humans
  • Male
  • Registries*

Substances

  • Complement C1 Inhibitor Protein